E. Siegel

发表

The use of flow microfluorometry for pharmaceutical testing.

E. Siegel, 1984, Regulatory toxicology and pharmacology : RTP.

The Tortoise and the Hare: Evolving Regulatory Landscapes for Biosimilars.

D. Hine, E. Siegel, V. Ferro, 2016, Trends in biotechnology.

Examination of the Regulatory Frameworks Applicable to Biologic Drugs (Including Stem Cells and Their Progeny) in Europe, the U.S., and Australia: Part I—A Method of Manual Documentary Analysis

N. Ilić, K. Atkinson, E. Siegel, 2012, Stem cells translational medicine.

Drugs and the aging.

E. Siegel, 1982, Regulatory toxicology and pharmacology : RTP.

Recombinant Vaccines: Development, Production, and Application

E. Siegel, R. Barnard, Luke R. Le Grand, 2012 .

A QUM partnership approach to regulating biosimilars in Australia

Vincent Chan, L. Nissen, E. Siegel, 2014 .

Precision Medicines Have Faster Approvals Based On Fewer And Smaller Trials Than Other Medicines.

Jonathan J. Darrow, A. Kesselheim, D. Hine, 2018, Health affairs.

Examination of the Regulatory Frameworks Applicable to Biologic Drugs (Including Stem Cells and Their Progeny) in Europe, the U.S., and Australia: Part II—A Method of Software Documentary Analysis

N. Ilić, K. Atkinson, E. Siegel, 2012, Stem cells translational medicine.